David B Clifford

Biographic Data

ID7729992
NAMEDavid B Clifford
GIVEN NAMESDavid B
FAMILY NAMEClifford
SIGNATURECLIFFORD D B
AFFILIATIONSWashington University in St. Louis
ORCID0000-0001-5719-1555
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2007
LATEST PUBLICATION YEAR2021
H-INDEX0

  • Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV

    Open AccessRowan Saloner, Judith D Lobo et al.ARTICLEAIDS and Behavior2021

    Despite the neurocognitive risks of aging with HIV, initial cross-sectional data suggest a subpopulation of older people with HIV (PWH) possess youthful neurocognition (NC) characteristic of SuperAgers (SA). Here we characterize longitudinal NC trajectories of older PWH and their convergent validity with baseline SA status, per established SuperAging criteria in PWH, and baseline biopsychosocial factors. Growth mixture modeling (GMM) identified l…

  • HIV and Aging

    Kevin P High, Mark Brennan-Ing et al.ARTICLEJAIDS Journal of Acquired Immune…2012

    HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Offi…

  • Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

    Open AccessDoyle E Patton, Steven Paul Wood et al.ARTICLEAIDS and Behavior2012

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy

    Open Accessfor the CHARTER and HNRC Groups, Robert K Heaton et al.ARTICLEJournal of NeuroVirology2011

    Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders (HAND) continue to be reported. Because large HIV-infected (HIV+) and uninfected (HIV-) groups have not been studied with similar methods in the pre-CART and CART eras, it is unclear whether CART has changed the prevalence, nature, and clinical correlates of HAND. We used compa…

  • Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy

    Brendan P Lucey, David B Clifford et al.ARTICLEAIDS Care2011

    Few studies have examined how patients with chronic HIV infection cope with pain and how pain relates to medication adherence. Pain coping strategies such as catastrophizing are often associated with increased pain and disability and may also influence adherence to medications. The goal of our study is to assess the relationship of catastrophizing and depression to pain, disability, and medication adherence through questionnaires administered to …

  • Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia

    Open AccessEdgar T Overton, John S K Kauwe et al.ARTICLEAIDS and Behavior2011

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

    Open AccessRobert K Heaton, David B Clifford et al.ARTICLENeurology2010

    OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatr…

  • Updated research nosology for HIV-associated neurocognitive disorders

    Open AccessAndrea Antinori, Gabriele Arendt et al.ARTICLENeurology2007

    In 1991, the AIDS Task Force of the American Academy of Neurology published nomenclature and research case definitions to guide the diagnosis of neurologic manifestations of HIV-1 infection. Now, 16 years later, the National Institute of Mental Health and the National Institute of Neurological Diseases and Stroke have charged a working group to critically review the adequacy and utility of these definitional criteria and to identify aspects that …